title: t(11;19)(q21;p12~p13.11) and MECT1-MAML2 fusion transcript expression as a prognostic marker in infantile lung mucoepidermoid carcinoma.
abstract: BACKGROUND
  Primary pulmonary mucoepidermoid carcinomas (MECs) are the third most frequent pulmonary malignant neoplasm in children, and new molecular diagnostics may prove useful in determining the biologic course of such tumors.
  
  
  METHODS
  We analyzed the presence of a balanced t(11;19)(q21; p12~p13.11) and the MECT1-MAML2 fusion transcript in a 9-year-old girl with mucoepidermoid lung carcinoma using conventional cytogenetics, fluorescence in-situ hybridization, spectral karyotyping, high-resolution multicolor banding, and reverse transcriptase-polymerase chain reaction.
  
  
  RESULTS
  We confirmed the t(11;19)(q21; p12~p13.11) in the tumor. Molecular analysis of the translocation breakpoint confirmed the presence of the MECT1-MAML2 fusion transcript postulated to lead to an altered cyclic adenosine monophosphate signaling in MEC.
  
  
  CONCLUSIONS
  Our data concur with previously reported cases, in which t(11;19) appears to be the primary chromosomal aberration for pulmonary MEC in children, and that the MECT1-MAML2 fusion transcript is associated with a better prognosis in MEC tumors.
authors.affiliation: Department of Pediatric Surgery, University of Dresden, D-01307 Dresden, Germany. alexandre.serra@uniklinikum-dresden.de
authors.forename: Alexandre
authors.initials: A
authors.lastname: Serra
authors.forename: Hans K
authors.initials: HK
authors.lastname: Schackert
authors.forename: B
authors.initials: B
authors.lastname: Mohr
authors.forename: Anja
authors.initials: A
authors.lastname: Weise
authors.forename: Thomas
authors.initials: T
authors.lastname: Liehr
authors.forename: Guido
authors.initials: G
authors.lastname: Fitze
mesh_terms: D014408:Biomarkers, Tumor / Q000032:analysis; D018277:Carcinoma, Mucoepidermoid / Q000235:genetics* / Q000473:pathology / Q000601:surgery; D002648:Child; D003582:Cytogenetics; D005260:Female; D006801:Humans; D017404:In Situ Hybridization, Fluorescence; D007621:Karyotyping; D008175:Lung Neoplasms / Q000235:genetics* / Q000473:pathology / Q000601:surgery; D015514:Oncogene Proteins, Fusion / Q000235:genetics*; D011379:Prognosis; D020133:Reverse Transcriptase Polymerase Chain Reaction; D014157:Transcription Factors
chemical_list: D014408:Biomarkers, Tumor; D015514:Oncogene Proteins, Fusion; D014157:Transcription Factors